[{"innerBlocks":[],"name":"core\/freeform","postId":624,"blockType":{"name":"core\/freeform","keywords":[],"attributes":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"providesContext":[],"usesContext":[],"selectors":[],"supports":{"className":false,"customClassName":false,"reusable":false},"styles":[],"variations":[],"apiVersion":3,"title":"Classic","description":"Use the classic WordPress editor.","category":"text"},"originalContent":"The National Association of Attorneys General wants the U.S. Senate and House of Representatives to get rid of decades-old regulations preventing doctors from knowing patient addiction treatment histories. In a letter to congressional leaders, 39 state AGs called on Congress to \u201creplace the cumbersome, out-of-date, privacy rules contained in 42 CFR Part 2 with the effective and more familiar privacy rules contained in the Health Insurance Portability and Accountability Act.\u201dCongress passed 42 CFR Part 2 more than 40 years ago out of concern about the potentially negative consequences\u2014including discrimination\u2014that could come from disclosing the patient records of individuals with substance use disorders.However, the AGs contend that the antiquated law prevents lifesaving medical care for patients in trying to recover from addiction.\u201c42 CFR Part 2 sets forth strict requirements for the use and disclosure of patients\u2019 substance use disorder treatment records,\u201d according to the AGs. \u201cThe complexities of complying with 42 CFR Part 2 often prevent general practice providers from even attempting to treat patients with substance use disorders through the use of medication-assisted treatment (MAT), because\u2013while providers are familiar with how to comply with the privacy requirements of HIPAA\u2013they may be intimidated by the requirements of 42 CFR Part 2.\u201d

Also See<\/b>: Feds issue guidance on substance abuse confidentiality law<\/a>In addition, their letter makes the case that \u201cwhile maintaining confidentiality is imperative to encouraging individuals to seek and obtain treatment, the inability to share records among providers can burden coordination of care, potentially resulting in harm to the patient.\u201dAs a result, the AGs urged Congress to align the rules regarding disclosure of substance use disorder treatment records with the protections against unwanted disclosure of patient records already contained in HIPAA. The letter points out that last year, the Protecting Jessica Grubb\u2019s Legacy Act was introduced by Sens. Joe Manchin (D-W.Va.) and Shelley Moore Capito (R-W.Va.), and the Overdose Prevention, and Patient Safety Act was introduced by Reps. Markwayne Mullin (R-Okla.) and Earl Blumenauer (D-Ore.).\u201cBoth bills will align Part 2 with HIPAA for the purposes of healthcare treatment, and both are supported by the Partnership to Amend 42 CFR Part 2, a growing coalition of more than 40 national healthcare organizations that includes the American Hospital Association, the American Psychiatric Association, and the American Society of Addiction Medicine,\u201d the letter concludes.","saveContent":"The National Association of Attorneys General wants the U.S. Senate and House of Representatives to get rid of decades-old regulations preventing doctors from knowing patient addiction treatment histories. In a letter to congressional leaders, 39 state AGs called on Congress to \u201creplace the cumbersome, out-of-date, privacy rules contained in 42 CFR Part 2 with the effective and more familiar privacy rules contained in the Health Insurance Portability and Accountability Act.\u201dCongress passed 42 CFR Part 2 more than 40 years ago out of concern about the potentially negative consequences\u2014including discrimination\u2014that could come from disclosing the patient records of individuals with substance use disorders.However, the AGs contend that the antiquated law prevents lifesaving medical care for patients in trying to recover from addiction.\u201c42 CFR Part 2 sets forth strict requirements for the use and disclosure of patients\u2019 substance use disorder treatment records,\u201d according to the AGs. \u201cThe complexities of complying with 42 CFR Part 2 often prevent general practice providers from even attempting to treat patients with substance use disorders through the use of medication-assisted treatment (MAT), because\u2013while providers are familiar with how to comply with the privacy requirements of HIPAA\u2013they may be intimidated by the requirements of 42 CFR Part 2.\u201dAlso See<\/b>: Feds issue guidance on substance abuse confidentiality law<\/a>In addition, their letter makes the case that \u201cwhile maintaining confidentiality is imperative to encouraging individuals to seek and obtain treatment, the inability to share records among providers can burden coordination of care, potentially resulting in harm to the patient.\u201dAs a result, the AGs urged Congress to align the rules regarding disclosure of substance use disorder treatment records with the protections against unwanted disclosure of patient records already contained in HIPAA. The letter points out that last year, the Protecting Jessica Grubb\u2019s Legacy Act was introduced by Sens. Joe Manchin (D-W.Va.) and Shelley Moore Capito (R-W.Va.), and the Overdose Prevention, and Patient Safety Act was introduced by Reps. Markwayne Mullin (R-Okla.) and Earl Blumenauer (D-Ore.).\u201cBoth bills will align Part 2 with HIPAA for the purposes of healthcare treatment, and both are supported by the Partnership to Amend 42 CFR Part 2, a growing coalition of more than 40 national healthcare organizations that includes the American Hospital Association, the American Psychiatric Association, and the American Society of Addiction Medicine,\u201d the letter concludes.","order":0,"get_parent":{},"attributes":[],"attributesType":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"dynamicContent":""}]

State AGs ask Congress to replace law on substance use disorder records

More for you